New eye imaging could reveal hidden clues to vision loss
NCT ID NCT07747662
First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time
Summary
This study explores whether combining three eye-imaging techniques can reveal how structural damage in the retina relates to vision loss in people with geographic atrophy, a form of age-related macular degeneration. Researchers will use OCT scans, ultra-high-resolution AOSLO imaging, and microperimetry to measure retinal sensitivity. The goal is to validate OCT-based measurements of photoreceptor damage by comparing them with direct visualization and functional tests. Ten participants from a larger study will undergo these imaging procedures to see if structural changes correlate with vision function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Adaptive Optics Scanning Light Ophthalmoscopy (AOSLO), Microperimetry, and Optical Coherence Tomography (OCT) imaging devices
- What this could lead to
- If successful, this could validate OCT as a reliable biomarker for vision loss in geographic atrophy, improving how the disease is monitored and treated.
- What could go wrong
- This is a small, early-stage validation study with only 10 participants, so results may not generalize. Imaging procedures are time-consuming and require specialized equipment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Wisconsin
Madison, Wisconsin, 53792, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new eye camera may spot stressed cells before vision loss begins
- Gene therapy injection aims to halt blinding eye disease
- Eye imaging showdown: which device measures macular damage best?
- Bionic eye implant aims to bring back sight in advanced macular degeneration
- New cell therapy aims to slow vision loss in retinal disease
- New pill aims to slow vision loss from dry macular degeneration